Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-01

Clinical Trial Update: Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 study evaluating ATS907 for primary open-angle glaucoma and ocular hypertension; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATS907 (ATS907)

Snippet

Sponsor: Altheos, Inc. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: UNKNOWN